Cart
sales@molnova.com
α-Conotoxin RgIA
CAS No. 876728-23-3
α-Conotoxin RgIA ( —— )
Catalog No. M38000 CAS No. 876728-23-3
α-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. α-Conotoxin RgIA can be obtained from Conus regius venom. α-Conotoxin RgIA can be used in the study of neurological diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 1160 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Nameα-Conotoxin RgIA
-
NoteResearch use only, not for human use.
-
Brief Descriptionα-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. α-Conotoxin RgIA can be obtained from Conus regius venom. α-Conotoxin RgIA can be used in the study of neurological diseases.
-
Descriptionα-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. α-Conotoxin RgIA can be obtained from Conus regius venom. α-Conotoxin RgIA can be used in the study of neurological diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number876728-23-3
-
Formula Weight1570.8
-
Molecular FormulaC59H95N25O18S4
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (63.66 mM)
-
SMILES——
-
Chemical NameGly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Arg-Tyr-Arg-Cys-Arg (Disulfide bridge:Cys2-Cys8;Cys3-Cys12)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ellison M, et al. Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR. Biochemistry. 2006 Feb 7;45(5):1511-7.
molnova catalog
related products
-
Super-TDU (TFA)
uper-TDU is an inhibitory peptide targeting YAP-TEADs interaction.
-
5,7-Dihydroxychromon...
5, 7-Dihydroxychromone isolated from DME is one of the active compounds that may contribute to regulate blood glucose levels.
-
FFAGLDD TFA
FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release.
